2月27日，君实生物（688180）A股报31.95元/股，涨幅0.95%，总市值约315亿元。2月26日单日，公司A股大涨10.59%、港股大涨 18.74%。公司A股股价近5个交易日累计涨幅超15%，近20日涨幅超23%，年内累计涨幅近17%，显著跑赢医药板块大盘。近期创新药板块受政策利好及市场情绪推动，君实生物作为肿瘤免疫疗法龙头企业表现突出。公司核心产品特瑞普利单抗（PD-1抑制剂）已在...
Source Link2月27日，君实生物（688180）A股报31.95元/股，涨幅0.95%，总市值约315亿元。2月26日单日，公司A股大涨10.59%、港股大涨 18.74%。公司A股股价近5个交易日累计涨幅超15%，近20日涨幅超23%，年内累计涨幅近17%，显著跑赢医药板块大盘。近期创新药板块受政策利好及市场情绪推动，君实生物作为肿瘤免疫疗法龙头企业表现突出。公司核心产品特瑞普利单抗（PD-1抑制剂）已在...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.